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What is it? Bcl10 is an
intracellular signalling protein
which positively regulates
lymphocyte proliferation by
connecting antigen receptor-
induced signals of B and T cells to
the activation of the transcription
factor NF-κB.
It first came to prominence… as
a candidate gene near the
chromosomal translocation
t(1;14)(p22;q32) found in B-cell
lymphomas of the mucosa
associated lymphoid tissue
(MALT). At the same time, Bcl10
was found by database searches
for novel proteins with a caspase
recruitment domain (CARD). Bcl
stands for B cell lymphoma or
leukemia, and is used for genes
found through chromosomal
translocations associated with
these diseases. Some other Bcl
proteins include the cell cycle
regulatory protein Bcl1/Cyclin D1
and the anti-apoptotic protein Bcl2.
Previously ascribed function... A
pro-apoptotic function was given
to Bcl10 based on overexpression
studies and on the characterization
of genetic mutations predicting the
expression of truncated, potentially
non-functional forms of Bcl10 in
lymphomas and other tumors.
Can we live without it? Probably
not, about one third of Bcl10
deficient mice embryos develop
lethal exencephaly. Surviving mice
are severely immunodeficient, and
their B and T lymphocytes are
defective in antigen receptor-
induced cellular activation and
proliferation.
Any related proteins? Several.
Its closest homologue is the
equine herpesvirus-2 protein E10,
which has an amino-terminal
CARD motif of about 50%
sequence identity with Bcl10.
Three CARD-containing proteins
of the membrane-associated
guanylate kinase (MAGUK) family,
designated CARMA (CARD-
MAGUK) or Bimp (Bcl10-
interacting MAGUK protein) also
have considerable CARD
sequence identity with Bcl10.
How does Bcl10 work? It’s not
clear, but the molecular
mechanism probably involves
binding of Bcl10’s amino-terminal
portion to the CARMA proteins via
a CARD–CARD interaction, and
binding of its carboxy-terminal
portion to MLT1, a caspase-like
molecule identified from another
recurrent chromosomal
translocation of MALT lymphomas. 
How does its herpesviral
homologue work? vE10 is
targeted to the plasma 
membrane via a covalent 
lipid modification where it 
induces phosphorylation and
membrane recruitment of Bcl10,
leading to the constitutive
activation of the transcription
factor NF-κB.
Is Bcl10 mutated in tumors?
Translocation of Bcl10 to the
immunoglobulin heavy chain locus
in the MALT-associated
chromosomal translocation
t(1;14)(p22;q32) predicts its
deregulated expression because
of the proximity of potent B cell
transcriptional enhancers or the
generation of mutant forms of
Bcl10 due to the action of the
immunoglobulin somatic
hypermutation mechanism.
Mutated forms of Bcl10 
encoding carboxy-terminal
truncations have been found, 
but whether they are expressed 
in MALT is an ongoing debate.
The phenotype of the Bcl10-
deficient mice suggests that
upregulation of Bcl10 or
expression of an active form of
Bcl10 might mimic a constitutive
NF-κB signal from the antigen
receptor and promote antigen
independent growth and
lymphoma progression.
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Figure 1. Bcl10 and its relatives
Bcl10, viral E10 and the three CARD-
containing MAGUKs (CARMA1, 2 and
3/Bimp3, 2 and 1/CARD11, 14 and 10)
contain an amino-terminal CARD motif.
The viral protein has a carboxy-terminal
consensus site (CysCys) for lipid modifi-
cation through a geranylgeranyl moiety.
The CARMA/Bimp homologues contain
other protein-protein interaction domains
(coiled coil, PDZ, SH3 and GUK).
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Figure 2. Working model for Bcl10.
Bcl10 is a positive regulator of antigen-
receptor induced NF-κB activation.
Members of the TRAF (TNF receptor
associated factor) family of scaffolding
proteins may relay Bcl10 to the NF-κB
signalling machinery. An interaction of
Bcl10 with PKCθ is suggested from the
similar phenotypes of the PKCθ and
Bcl10 knock-out mice — lack of NF-κB-
dependent T-cell activation.
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